Cresp 200mcg Injection is a medication used to stimulate the production of red blood cells in the body. Its active ingredient is Darbepoetin alfa, a synthetic form of erythropoietin. Darbepoetin alfa works by binding to the erythropoietin receptor on red blood cell precursors in the bone marrow, stimulating their proliferation and differentiation into mature red blood cells. This process increases the oxygen-carrying capacity of the blood.
Cresp 200mcg Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) in both dialysis-dependent and non-dialysis-dependent patients. It is also used to treat anemia in adult patients with cancer receiving chemotherapy. The dosage and administration of Cresp 200mcg Injection should be determined by a healthcare professional based on the individual patient’s condition, hemoglobin levels, and response to treatment. It is typically administered subcutaneously or intravenously.
Common side effects may include headache, nausea, vomiting, diarrhea, and pain at the injection site. More serious side effects, such as hypertension, blood clots, and allergic reactions, can occur. Patients should inform their doctor about any pre-existing medical conditions, especially cardiovascular disease or a history of seizures. Cresp 200mcg Injection should be stored at a temperature between 2°C and 8°C (36°F and 46°F) and protected from light. Do not freeze.
